-

EU’s Vaccine Obstructionism is Self-defeating, says AHF

LOS ANGELES--(BUSINESS WIRE)--An EU Ambassador has dismissed as premature a call by India to urgently convene a World Trade Organization (WTO) Ministerial Conference to continue moving forward the debate on a proposed waiver of intellectual property rights protections on COVID-19 vaccines. AIDS Healthcare Foundation (AHF) characterized this EU position as reprehensible and dimwitted.

“Europe is sawing off the branch it’s sitting on. In the next two months, Omicron could infect 50% of Europeans, according to the WHO, but the EU is blocking the one thing that can help stop the constant cycle of variants – expanded access to vaccines around the world,” said AHF President Michael Weinstein. “Considering this kind of obstructionism flies in the face of science and public health, Einstein’s famous quote is fitting to describe the EU’s behavior: ‘Insanity is doing the same thing over and over and expecting different results.’”

India and South Africa advanced a proposal at the WTO to suspend patent protections on COVID-19 vaccines over a year ago. While the United States and many other nations support this measure, the EU and several other wealthy countries have done their utmost to stall the debate. It remains to be seen if growing social unrest in Europe and financial shocks brought on by repeated lockdowns will be enough to convince the EU that the current course of action on vaccine hoarding and protectionism is not sustainable during a pandemic.

AIDS Healthcare Foundation (AHF), the largest global AIDS organization, currently provides medical care and/or services to over 1.6 million clients in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

AIDS Healthcare Foundation


Release Versions

Contacts

US MEDIA CONTACT:
Ged Kenslea, Senior Director, Communications, AHF
+1.323.308.1833 work +1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy &
Communications, AHF
+1 323.308.1829
denys.nazarov@ahf.org

Social Media Profiles
More News From AIDS Healthcare Foundation

AHF: Florida Lawmakers Reverse HIV Drug Cuts, Restoring Coverage for Thousands

TALLAHASSEE, Fla.--(BUSINESS WIRE)--Thousands of Floridians living with HIV will keep the medication that keeps them alive, after the Florida Legislature today passed a state budget that reverses this year's cuts to the AIDS Drug Assistance Program (ADAP). The budget returns eligibility to 400 percent of the federal poverty level, brings back the medications the Department of Health had dropped, including Biktarvy, funds the program with $75 million, and adds independent oversight. "This is wha...

AHF Calls for Access and Dignity on Menstrual Health Day

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) joins the global commemoration of Menstrual Health Day with events across nearly 50 countries, highlighting the importance of reducing period stigma and expanding access to affordable menstrual products—critical steps in protecting overall health and reducing vulnerability to HIV and other sexually transmitted infections. Menstrual Health Day is observed annually on May 28. Around the world, barriers to menstrual health continue to...

Ebola Crisis Exposes Failure of Current Global Health Architecture, says AHF

LOS ANGELES--(BUSINESS WIRE)--As Uganda and the Democratic Republic of the Congo (DRC) confront a rapidly evolving Ebola outbreak, AIDS Healthcare Foundation (AHF) warns that the crisis highlights persistent weaknesses in the world’s ability to respond quickly and equitably to emerging infectious disease threats. The current outbreak involves the Bundibugyo strain of Ebola virus, for which no approved vaccines or therapeutics currently exist, heightening concerns among global health officials a...
Back to Newsroom